approved EB-2 (NIW)

Research Lab Specialist Senior

Physiology · Turkey · 2025-02-06

Processing Time
60 days
Decision Date
2025-02-06
Location
Michigan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research into the molecular mechanisms behind brain metastasis originating from primary tumors, specifically identifying pathways that contribute to cancer spread. This work aims to enable new therapeutic interventions for metastatic breast cancer and improve patient survival outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical public health challenges in metastatic breast cancer and has broad relevance to neurobiology.

2 Well Positioned to Advance the Endeavor Met

The petitioner has a robust portfolio of 34 publications and over 1,100 citations, demonstrating significant influence in the field.

3 Balance of Factors Met

The urgency of improving cancer treatment outcomes and the petitioner's proven expertise make a waiver of labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's scholarly record of 34 peer-reviewed journal articles and 1,125 citations. Evidence also included 15 formal peer reviews and a role as a review editor, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Others

Healthcare · Egypt

WeGreened EB-2 (NIW) approved
289 days 2022-10-12
The petitioner proposes to investigate brain cancer molecular biology to develop novel diagnostic and prognostic approaches for early tumor detection. Additionally, the work focuses on improving the safety and cost-effectiveness of microsurgical techniques for skull-base and deep brain tumor surgeries.

Postdoctoral Researcher

Healthcare · Japan

WeGreened EB-2 (NIW) approved
California 126 days 2023-01-21
The petitioner proposes to continue applying bioinformatics, genomics, transcriptomics, and genome engineering techniques to analyze and develop immunotherapeutic strategies such as vaccines, cell therapies, and virus therapies. This work aims to improve the prognosis and management of malignant brain tumors within the U.S. healthcare system.

Postdoctoral Researcher

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
69 days 2026-01-26
The petitioner proposes to continue research on elucidating molecular mechanisms and identifying novel therapeutics for rare and advanced metastatic cancers. The work involves using cell-based assays, advanced biotechnological approaches, and computer-aided drug design to advance personalized medicine and improve patient survival outcomes.

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-06.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 60 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist